Puma Biotechnology Correlations
| PBYI Stock | USD 6.16 0.20 3.36% |
The current 90-days correlation between Puma Biotechnology and Abeona Therapeutics is -0.41 (i.e., Very good diversification). The correlation of Puma Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Puma Biotechnology Correlation With Market
Significant diversification
The correlation between Puma Biotechnology and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Puma Stock
| 0.73 | VERA | Vera Therapeutics | PairCorr |
| 0.73 | DXB | Dimerix | PairCorr |
| 0.61 | 0P6S | Bayer AG NA | PairCorr |
| 0.73 | VNDA | Vanda Pharmaceuticals | PairCorr |
Moving against Puma Stock
| 0.63 | CMB | Cambium Bio | PairCorr |
| 0.63 | PYC | Physiomics Plc | PairCorr |
| 0.36 | DRMA | Dermata Therapeutics Buyout Trend | PairCorr |
| 0.36 | SABSW | SAB Biotherapeutics | PairCorr |
| 0.33 | VIVS | VivoSim Labs, Symbol Change | PairCorr |
| 0.31 | AVH | Avita Medical | PairCorr |
| 0.6 | 300238 | Guanhao Biotech | PairCorr |
| 0.51 | 300676 | BGI Genomics | PairCorr |
| 0.44 | VTGN | VistaGen Therapeutics | PairCorr |
| 0.44 | ENSC | Ensysce Biosciences | PairCorr |
| 0.41 | BSFA | BSF Enterprise Plc | PairCorr |
| 0.4 | ALA | Arovella Therapeutics | PairCorr |
| 0.39 | ELUT | Elutia Inc | PairCorr |
| 0.38 | EGRX | Eagle Pharmaceuticals | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Puma Stock performing well and Puma Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Puma Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ELDN | 4.71 | (0.22) | 0.00 | 0.23 | 0.00 | 9.22 | 70.46 | |||
| ABEO | 2.90 | 0.12 | 0.01 | (0.25) | 3.48 | 6.16 | 26.76 | |||
| VYGR | 3.01 | (0.04) | 0.00 | 0.04 | 3.43 | 6.22 | 21.00 | |||
| AVIR | 1.69 | 0.26 | 0.09 | 0.25 | 2.54 | 4.38 | 17.80 | |||
| ARCT | 4.66 | (1.29) | 0.00 | (4.80) | 0.00 | 7.43 | 61.30 | |||
| ALLO | 3.64 | 0.16 | 0.06 | 0.12 | 4.46 | 8.89 | 27.43 | |||
| HUMA | 4.46 | (0.70) | 0.00 | (0.13) | 0.00 | 8.93 | 51.56 | |||
| TRDA | 2.93 | 0.91 | 0.28 | 0.73 | 2.60 | 7.03 | 20.54 | |||
| SGMT | 3.54 | 0.03 | 0.00 | 0.05 | 0.00 | 6.39 | 36.94 |
Puma Biotechnology Corporate Management
| Jeffrey Ludwig | Chief Officer | Profile | |
| Roger Storms | Senior Sales | Profile | |
| Alvin Pharmd | Chief Officer | Profile | |
| Heather Blaber | Senior Marketing | Profile | |
| FRAPS BSc | Pharmacovigilance, Affairs | Profile |